Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

NCT03109249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Breast Cancer

Interventions

DRUG: SPARC1613
DRUG: Reference1613

Sponsor

Sun Pharma Advanced Research Company Limited